S227: INITIAL SAFETY DATA FROM THE PHASE 3 POLAR BEAR TRIAL IN ELDERLY OR FRAIL PATIENTS WITH DIFFUSE LARGE CELL LYMPHOMA, COMPARING R-POLA-MINI-CHP AND R-MINI-CHOP

• Mats Jerkeman,
• Sirpa Leppä,
• Julian Hamfjord,
• Peter Brown,
• Sara Ekberg,
• Andrés José María Ferreri

Affiliations

Mats Jerkeman

1 Lund University, Lund, Sweden

Sirpa Leppä

2 University of Helsinki and Helsinki University Hospital Comprehensive Cancer Centre, Helsinki, Finland

Julian Hamfjord

3 Norwegian Radium Hospital, Oslo, Norway

Peter Brown

4 Rigshospitalet, Copenhagen, Denmark

Sara Ekberg

5 Karolinska Institute, Stockholm, Sweden

Andrés José María Ferreri

6 IRCCS San Raffaele Scientific Institute, Milan, Italy